From January 1, 2023 to March 31, 2023, the company has repurchased 309,012 shares, representing 1% for $0.48 million. With this, the company has completed the repurchase of 4,190,670 shares, representing 12.61% for $14.7 million under the buyback announced on March 15, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 USD | -0.97% | -6.42% | -23.31% |
05-13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
05-09 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.31% | 32.22M | |
-27.43% | 16.87B | |
-40.65% | 2.95B | |
+14.84% | 1.82B | |
-8.11% | 1.57B | |
+28.95% | 1.35B | |
-17.64% | 938M | |
-27.00% | 848M | |
+3.61% | 812M | |
-27.02% | 613M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.